Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Type I collagen inhibits differentiation and promotes a stem cell-like phenotype in human colorectal carcinoma cells.

Kirkland SC.

Br J Cancer. 2009 Jul 21;101(2):320-6. doi: 10.1038/sj.bjc.6605143. Epub 2009 Jun 30.

2.

Alpha2beta1 integrin regulates lineage commitment in multipotent human colorectal cancer cells.

Kirkland SC, Ying H.

J Biol Chem. 2008 Oct 10;283(41):27612-9. doi: 10.1074/jbc.M802932200. Epub 2008 Jul 29.

4.

Prostaglandin J2 and 15-deoxy-delta12,14-prostaglandin J2 induce proliferation of cyclooxygenase-depleted colorectal cancer cells.

Chinery R, Coffey RJ, Graves-Deal R, Kirkland SC, Sanchez SC, Zackert WE, Oates JA, Morrow JD.

Cancer Res. 1999 Jun 1;59(11):2739-46.

5.

Antioxidants reduce cyclooxygenase-2 expression, prostaglandin production, and proliferation in colorectal cancer cells.

Chinery R, Beauchamp RD, Shyr Y, Kirkland SC, Coffey RJ, Morrow JD.

Cancer Res. 1998 Jun 1;58(11):2323-7.

6.

Inhibition of growth and enhancement of differentiation of colorectal carcinoma cell lines by MAb MR6 and IL-4.

Al-Tubuly AA, Spijker R, Pignatelli M, Kirkland SC, Ritter MA.

Int J Cancer. 1997 May 16;71(4):605-11.

7.

Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2.

Sheng H, Shao J, Kirkland SC, Isakson P, Coffey RJ, Morrow J, Beauchamp RD, DuBois RN.

J Clin Invest. 1997 May 1;99(9):2254-9.

8.

Epidermal growth factor receptor activation induces nuclear targeting of cyclooxygenase-2, basolateral release of prostaglandins, and mitogenesis in polarizing colon cancer cells.

Coffey RJ, Hawkey CJ, Damstrup L, Graves-Deal R, Daniel VC, Dempsey PJ, Chinery R, Kirkland SC, DuBois RN, Jetton TL, Morrow JD.

Proc Natl Acad Sci U S A. 1997 Jan 21;94(2):657-62.

9.
10.

Organisation and gel contraction by human colonic carcinoma (HCA-7) sublines grown in 3-dimensional collagen gel.

Kirkland SC, Henderson K, Liu D, Pignatelli M.

Int J Cancer. 1995 Mar 16;60(6):877-82.

PMID:
7896461
13.

CNS: special skill really contains costs!

Kirkland SC, Tinsley D.

Nurs Manage. 1990 Sep;21(9):97-8. No abstract available.

PMID:
2402393
15.
16.

Variation in HLA expression on tumors: an escape from immune response.

Smith ME, Bodmer JG, Kelly AP, Trowsdale J, Kirkland SC, Bodmer WF.

Cold Spring Harb Symp Quant Biol. 1989;54 Pt 1:581-6. Review. No abstract available.

PMID:
2517922
18.
19.

Calcium- and cyclic AMP-dependent chloride secretion in human colonic epithelia.

Cuthbert AW, Egléme C, Greenwood H, Hickman ME, Kirkland SC, MacVinish LJ.

Br J Pharmacol. 1987 Jul;91(3):503-15.

20.

Accessibility of antigenic sites recognized by AUA1, HMFG1 and HMFG2 monoclonal antibodies: its influence on antibody binding of live cells.

Mooi WJ, Krausz T, Kirkland SC, Cross A, Epenetos AA.

Int J Biol Markers. 1987 May-Aug;2(2):57-63.

PMID:
2454274
21.
22.
23.
24.
25.

Further characterization of corticotrophin releasing factor activity from a bronchial tumour.

Kirkland SC, Lumsden JL, Ellison ML.

J Endocrinol. 1984 Oct;103(1):91-6.

PMID:
6332874
26.
27.

Studies on the corticotrophin releasing activity of a posterior pituitary extract.

Kirkland SC, Ellison ML.

J Endocrinol. 1981 Jun;89(3):423-9.

PMID:
6265579
28.

A dose interpolation routine for multiple dilutions in radioimmunoassay.

Laurence DJ, Kirkland SC, Ellison ML.

Ann Clin Biochem. 1980 Mar;17(2):91-4.

PMID:
6156635

Supplemental Content

Loading ...
Support Center